data_1u0p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1u0p _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 120.727 0.299 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -94.71 134.17 37.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.419 0.628 . . . . 0.0 112.681 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.15 159.06 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HG3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -98.93 96.13 7.63 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.8 0.81 . . . . 0.0 109.836 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HD3' ' CG2' ' A' ' 21' ' ' VAL . 1.4 mtpp -110.49 135.94 50.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.084 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 57.08 32.08 21.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.901 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.48 8.56 80.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.584 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.3 mt-10 -125.41 157.71 36.18 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.586 0.708 . . . . 0.0 110.885 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 15' ' ' ARG . 73.4 m95 -86.61 122.03 29.95 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.536 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -136.21 138.88 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.843 0 CA-C-O 122.77 1.271 . . . . 0.0 113.606 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 CA-C-O 121.393 0.616 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.8 m-85 -77.9 134.58 37.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.5 157.5 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 174.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 96.25 7.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.929 0.871 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 21' ' ' VAL . 6.6 mmmm -110.57 136.64 49.37 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 53.93 28.63 8.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.53 0.01 89.59 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.966 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.6 mt-10 -119.85 159.78 23.93 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.451 0.643 . . . . 0.0 110.887 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -84.11 131.74 34.76 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.447 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.604 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -130.87 130.95 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.713 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.943 0 CA-C-O 122.492 1.139 . . . . 0.0 112.277 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.99 135.05 33.76 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.76 159.95 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.8 OUTLIER -99.27 96.82 8.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.056 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HG2' HG21 ' A' ' 21' ' ' VAL . 3.2 mmtp -109.73 136.65 48.73 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.98 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 54.06 30.67 12.31 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.04 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.73 2.3 88.04 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.817 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.9 mt-10 -121.07 160.24 24.05 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.525 0.679 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.403 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 78.8 m95 -86.26 125.32 33.49 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.439 HG21 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.5 137.59 45.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 122.753 1.264 . . . . 0.0 113.212 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.247 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.503 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.12 135.44 33.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.944 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.89 161.3 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -99.63 96.17 7.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.934 0.873 . . . . 0.0 110.195 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HG2' HG22 ' A' ' 21' ' ' VAL . 1.5 mmmm -110.93 137.1 48.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.934 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.0 t0 55.57 30.85 16.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.87 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.15 79.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.388 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -122.61 157.18 32.73 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.51 0.671 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -82.92 123.3 29.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.958 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG22 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -134.08 135.58 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.605 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.961 0 CA-C-O 122.833 1.302 . . . . 0.0 113.228 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 121.536 0.684 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.475 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.9 m-85 -79.24 136.07 36.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.581 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.7 157.79 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 173.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.2 96.12 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.949 0.88 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.628 ' HG2' HG22 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.3 136.78 48.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.682 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.3 t0 54.64 28.46 10.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.191 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.25 0.79 90.09 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.036 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -121.42 160.65 23.68 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.426 0.631 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -84.18 131.69 34.74 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.657 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.628 HG22 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.7 131.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 176.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.7 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 122.353 1.073 . . . . 0.0 111.544 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.491 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -91.02 134.31 34.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.91 159.87 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 96.48 8.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.931 0.872 . . . . 0.0 109.632 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' CD ' HG21 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.52 136.67 49.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.861 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 56.77 30.5 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.917 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.47 5.68 82.82 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.653 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -124.96 160.32 29.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.524 0.678 . . . . 0.0 110.849 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -85.47 120.96 27.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.432 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.424 HG21 ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -135.66 139.85 45.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.501 -0.915 0 CA-C-O 122.674 1.226 . . . . 0.0 113.397 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.063 0.458 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.488 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -90.18 135.59 33.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.41 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.77 159.39 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.94 96.52 7.6 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.871 0.843 . . . . 0.0 110.173 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' GLU . 2.2 mmtp -110.03 136.12 49.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.038 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.31 30.29 12.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.941 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.39 88.2 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.769 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -118.46 159.79 22.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.627 0.727 . . . . 0.0 110.952 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -87.12 126.57 34.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.613 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -136.96 135.31 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.607 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 122.777 1.275 . . . . 0.0 113.539 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 121.011 0.434 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.76 136.34 33.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.995 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.56 159.34 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 1.6 ttt180 -98.93 96.59 7.95 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.874 0.845 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HG2' HG21 ' A' ' 21' ' ' VAL . 23.3 mmmt -110.43 137.03 48.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 54.92 30.46 14.0 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.069 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.33 87.21 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.745 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.4 mt-10 -122.65 159.84 27.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.514 0.673 . . . . 0.0 110.889 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.42 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.2 m95 -85.43 126.65 33.96 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.468 HG21 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.74 136.54 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.63 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 122.823 1.297 . . . . 0.0 113.516 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.424 0.63 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.8 m-85 -78.36 134.87 37.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.25 157.48 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.77 96.2 7.44 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.938 0.875 . . . . 0.0 110.942 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HG2' HG21 ' A' ' 21' ' ' VAL . 2.3 mmmt -110.79 136.37 49.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.754 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.2 t0 54.59 28.14 9.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.129 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.63 -1.18 89.11 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.018 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.8 mt-10 -119.6 160.77 21.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.376 0.607 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 80.2 m95 -84.84 132.35 34.41 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.743 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.614 HG21 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.28 130.74 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.72 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.976 0 CA-C-O 122.461 1.124 . . . . 0.0 111.769 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 120.93 0.395 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.5 135.46 33.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.926 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 160.1 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -98.25 96.79 8.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.907 0.861 . . . . 0.0 110.016 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 19' ' ' GLU . 37.8 mmtt -109.51 137.29 47.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.877 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.7 t70 53.81 30.65 11.69 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.015 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.84 86.52 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.615 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.5 mt-10 -123.01 159.02 29.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.483 0.659 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.42 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.3 m95 -83.99 124.84 31.47 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.593 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.619 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 122.633 1.206 . . . . 0.0 113.01 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.208 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.442 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 10.8 t80 -70.68 139.79 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.719 0.295 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 mt -100.57 98.85 8.74 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.417 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 94.8 Cg_endo -84.24 122.81 2.93 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.635 2.224 . . . . 0.0 112.391 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.87 84.94 1.24 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.013 0.435 . . . . 0.0 110.944 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.41 134.01 86.94 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.139 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.96 97.02 0.96 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.332 2.021 . . . . 0.0 111.955 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 10' ' ' GLY . 17.7 tpp85 -124.76 156.89 36.98 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.649 0.737 . . . . 0.0 110.392 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -143.45 10.13 1.64 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.928 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 8' ' ' ARG . . . -109.35 4.18 31.31 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.206 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -126.76 131.21 51.36 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.933 -0.634 . . . . 0.0 110.88 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.64 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -129.95 133.34 46.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.402 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -94.71 134.17 37.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.419 0.628 . . . . 0.0 112.681 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.15 159.06 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HG3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -98.93 96.13 7.63 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.8 0.81 . . . . 0.0 109.836 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HD3' ' CG2' ' A' ' 21' ' ' VAL . 1.4 mtpp -110.49 135.94 50.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.084 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 57.08 32.08 21.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.901 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.48 8.56 80.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.584 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.3 mt-10 -125.41 157.71 36.18 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.586 0.708 . . . . 0.0 110.885 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 15' ' ' ARG . 73.4 m95 -86.61 122.03 29.95 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.536 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -136.21 138.88 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -92.8 145.21 24.57 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 122.77 1.271 . . . . 0.0 113.606 -178.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -165.22 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 112.392 -2.186 . . . . 0.0 110.154 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.91 149.61 29.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.9 0.381 . . . . 0.0 111.043 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.27 -79.02 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.027 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.75 153.11 21.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.948 0.404 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.003 -179.89 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -99.15 141.27 32.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.811 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.05 98.99 7.11 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.47 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.52 126.14 10.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.418 2.079 . . . . 0.0 112.177 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.54 110.16 6.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.889 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.67 120.63 76.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.6 141.07 75.42 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.35 2.033 . . . . 0.0 112.121 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.44 154.26 36.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.567 0.699 . . . . 0.0 110.476 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.445 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . 13.5 t0 -147.41 14.71 1.11 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.436 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.06 10.42 56.35 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.699 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 3.6 mm100 -81.03 134.49 35.68 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.635 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.98 113.9 20.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.393 0.616 . . . . 0.0 109.787 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.8 m-85 -77.9 134.58 37.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.5 157.5 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 174.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 96.25 7.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.929 0.871 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 21' ' ' VAL . 6.6 mmmm -110.57 136.64 49.37 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 53.93 28.63 8.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.53 0.01 89.59 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.966 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.6 mt-10 -119.85 159.78 23.93 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.451 0.643 . . . . 0.0 110.887 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -84.11 131.74 34.76 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.447 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.604 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -130.87 130.95 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.713 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.48 129.49 37.45 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 122.492 1.139 . . . . 0.0 112.277 -177.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.3 mt -77.41 -175.43 3.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 112.845 -1.98 . . . . 0.0 111.167 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -159.7 55.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.598 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.46 -102.19 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.148 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 27' ' ' LEU . 54.2 p90 -87.32 -164.67 1.12 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.624 0.249 . . . . 0.0 110.922 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 2.0 mm? . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -100.86 116.51 32.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.541 ' H ' ' CD1' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -77.81 112.44 24.79 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.242 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.45 149.46 65.87 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.508 2.139 . . . . 0.0 112.195 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.4 90.29 1.28 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.038 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.55 ' N ' ' CD ' ' A' ' 7' ' ' PRO . . . -70.85 -39.65 9.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.925 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 6' ' ' ALA . 89.0 Cg_exo -47.4 105.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.265 1.977 . . . . 0.0 112.611 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.95 158.24 34.08 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.593 0.711 . . . . 0.0 110.527 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -144.43 11.52 1.49 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.437 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.28 8.69 51.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.659 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -88.68 134.66 33.83 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.7 -0.75 . . . . 0.0 111.064 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -126.75 128.42 46.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.088 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.478 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.99 135.05 33.76 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.76 159.95 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.8 OUTLIER -99.27 96.82 8.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.056 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HG2' HG21 ' A' ' 21' ' ' VAL . 3.2 mmtp -109.73 136.65 48.73 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.98 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 54.06 30.67 12.31 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.04 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.73 2.3 88.04 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.817 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.9 mt-10 -121.07 160.24 24.05 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.525 0.679 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.403 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 78.8 m95 -86.26 125.32 33.49 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.439 HG21 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.5 137.59 45.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -90.85 143.89 26.26 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 122.753 1.264 . . . . 0.0 113.212 -178.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.6 mt -62.45 -165.98 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.001 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.86 -156.86 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.378 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -72.52 -60.54 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.796 0.332 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -87.24 -60.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.775 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.901 -0.08 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -74.69 128.98 36.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.106 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.1 118.62 67.85 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.561 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.2 161.6 10.94 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.521 2.147 . . . . 0.0 112.247 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.84 82.43 0.46 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.469 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.658 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -72.36 -46.29 10.44 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.525 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -43.97 113.68 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.533 2.155 . . . . 0.0 112.784 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -124.93 156.72 37.54 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.622 0.725 . . . . 0.0 110.743 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.587 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . 8.4 t70 -145.9 12.55 1.27 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.303 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.37 8.77 59.9 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.541 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.587 ' HG3' ' HB3' ' A' ' 9' ' ' ASP . 38.3 mt-30 -85.52 131.4 34.38 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.782 -0.709 . . . . 0.0 111.329 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -122.86 123.55 41.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.503 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.12 135.44 33.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.944 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.89 161.3 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -99.63 96.17 7.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.934 0.873 . . . . 0.0 110.195 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HG2' HG22 ' A' ' 21' ' ' VAL . 1.5 mmmm -110.93 137.1 48.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.934 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.0 t0 55.57 30.85 16.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.87 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.15 79.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.388 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -122.61 157.18 32.73 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.51 0.671 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -82.92 123.3 29.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.958 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG22 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -134.08 135.58 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.605 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.08 145.2 24.89 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.833 1.302 . . . . 0.0 113.228 -178.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.3 mt -67.43 -1.26 4.56 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 112.299 -2.228 . . . . 0.0 112.08 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.416 ' OG ' ' HG2' ' A' ' 11' ' ' GLN . 0.4 OUTLIER -83.04 161.27 21.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.901 0.381 . . . . 0.0 111.266 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.4 t -84.41 -172.99 4.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.526 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -86.84 142.16 28.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.951 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.475 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -105.51 104.25 13.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.744 0.307 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.19 105.71 37.48 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.265 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.59 113.32 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.401 2.067 . . . . 0.0 112.029 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.25 81.09 1.0 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.0 111.128 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.39 118.13 67.39 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.035 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.56 94.32 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.244 1.963 . . . . 0.0 111.939 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.34 156.35 42.13 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.592 0.711 . . . . 0.0 110.499 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -143.44 11.33 1.7 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.404 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.93 8.33 57.65 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.503 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -89.46 134.0 34.3 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.624 -0.788 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -122.71 113.58 19.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.04 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.475 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.9 m-85 -79.24 136.07 36.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.581 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.7 157.79 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 173.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.2 96.12 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.949 0.88 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.628 ' HG2' HG22 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.3 136.78 48.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.682 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.3 t0 54.64 28.46 10.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.191 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.25 0.79 90.09 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.036 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -121.42 160.65 23.68 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.426 0.631 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -84.18 131.69 34.74 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.657 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.628 HG22 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.7 131.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 176.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.7 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -90.93 135.22 33.88 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.353 1.073 . . . . 0.0 111.544 -177.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.4 mt -70.36 46.21 0.08 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.735 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 t -89.75 89.4 7.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.64 0.257 . . . . 0.0 110.534 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.1 m -78.29 -85.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.766 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.93 -27.33 15.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.79 0.328 . . . . 0.0 110.984 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.856 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -77.35 144.61 37.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.704 0.288 . . . . 0.0 110.815 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.508 ' H ' ' CD1' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -78.1 111.15 16.35 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.253 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.1 144.67 30.2 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.453 2.102 . . . . 0.0 112.38 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -72.3 87.34 1.13 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.005 0.431 . . . . 0.0 110.805 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.589 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -67.21 -46.25 50.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.727 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 39.2 Cg_endo -67.0 128.12 18.11 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.766 1.644 . . . . 0.0 111.986 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -124.55 155.79 38.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.687 0.756 . . . . 0.0 110.222 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -142.55 15.19 1.99 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.059 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.31 4.13 63.38 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.591 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -96.17 147.45 23.74 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.76 -0.72 . . . . 0.0 111.297 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -127.75 135.55 50.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.369 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.491 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -91.02 134.31 34.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.91 159.87 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 96.48 8.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.931 0.872 . . . . 0.0 109.632 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' CD ' HG21 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.52 136.67 49.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.861 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 56.77 30.5 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.917 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.47 5.68 82.82 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.653 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -124.96 160.32 29.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.524 0.678 . . . . 0.0 110.849 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -85.47 120.96 27.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.432 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.424 HG21 ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -135.66 139.85 45.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -92.17 144.4 25.46 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 122.674 1.226 . . . . 0.0 113.397 -178.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mt -66.44 -169.58 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 112.5 -2.136 . . . . 0.0 110.012 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -152.97 117.62 5.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 t -82.98 -172.28 4.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.816 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -87.22 -69.04 0.71 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.869 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -70.59 143.71 51.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.782 0.325 . . . . 0.0 111.02 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -88.95 112.33 50.17 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.176 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.11 123.2 13.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.307 2.005 . . . . 0.0 112.208 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -72.95 95.65 2.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.253 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.98 122.89 88.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.66 140.84 24.13 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.346 2.031 . . . . 0.0 112.154 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -113.15 153.23 28.59 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.628 0.727 . . . . 0.0 110.084 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -147.76 10.83 0.95 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.432 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.32 3.55 61.73 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.253 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -125.55 132.45 52.58 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.482 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -128.56 124.97 37.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.063 0.458 . . . . 0.0 110.381 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.488 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -90.18 135.59 33.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.41 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.77 159.39 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.94 96.52 7.6 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.871 0.843 . . . . 0.0 110.173 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' GLU . 2.2 mmtp -110.03 136.12 49.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.038 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.31 30.29 12.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.941 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.39 88.2 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.769 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -118.46 159.79 22.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.627 0.727 . . . . 0.0 110.952 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -87.12 126.57 34.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.613 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -136.96 135.31 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.607 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.6 143.88 26.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.777 1.275 . . . . 0.0 113.539 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.422 HD13 ' HB1' ' A' ' 12' ' ' ALA . 21.4 mt -65.61 -174.83 0.22 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 112.268 -2.242 . . . . 0.0 110.895 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 t -72.09 134.96 46.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.831 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.0 149.11 28.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -125.61 -68.02 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.591 -0.203 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -119.49 104.11 10.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 0.0 110.703 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 3' ' ' ILE . 4.2 mt -93.05 108.99 36.68 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.378 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.71 146.64 61.11 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.492 2.128 . . . . 0.0 111.974 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.06 84.31 0.99 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.529 ' N ' ' CD ' ' A' ' 7' ' ' PRO . . . -72.86 -40.75 6.46 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.909 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 6' ' ' ALA . 80.1 Cg_exo -47.73 101.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.133 1.889 . . . . 0.0 112.422 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HB3' ' NH1' ' A' ' 8' ' ' ARG . 13.3 ttp-105 -124.99 154.27 41.48 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.498 0.666 . . . . 0.0 110.675 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -145.23 11.19 1.32 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.476 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' H ' ' HG2' ' A' ' 8' ' ' ARG . . . 71.31 7.55 63.9 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.122 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -95.52 135.84 36.66 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.413 -0.894 . . . . 0.0 110.946 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -127.08 128.3 46.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.011 0.434 . . . . 0.0 110.078 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.76 136.34 33.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.995 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.56 159.34 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 1.6 ttt180 -98.93 96.59 7.95 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.874 0.845 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HG2' HG21 ' A' ' 21' ' ' VAL . 23.3 mmmt -110.43 137.03 48.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 54.92 30.46 14.0 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.069 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.33 87.21 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.745 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.4 mt-10 -122.65 159.84 27.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.514 0.673 . . . . 0.0 110.889 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.42 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.2 m95 -85.43 126.65 33.96 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.468 HG21 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -137.74 136.54 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.63 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.27 143.38 26.71 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.823 1.297 . . . . 0.0 113.516 -178.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.424 ' HB3' ' H ' ' A' ' 24' ' ' SER . 1.0 OUTLIER -64.21 -159.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 112.086 -2.324 . . . . 0.0 110.278 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.424 ' H ' ' HB3' ' A' ' 23' ' ' LEU . 1.7 t 49.38 106.09 0.0 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.972 0.415 . . . . 0.0 111.852 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.6 m -78.02 153.45 32.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.152 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -91.9 -176.28 4.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.432 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -73.34 111.79 8.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.99 105.54 12.63 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.279 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.81 116.37 4.53 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.388 2.058 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.23 144.61 46.68 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.293 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.15 118.6 63.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.01 136.17 9.07 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.572 2.181 . . . . 0.0 112.749 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -120.3 155.98 32.2 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.569 0.7 . . . . 0.0 110.24 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -147.36 13.58 1.09 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.759 -1.109 . . . . 0.0 113.145 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.49 11.45 41.35 Favored Glycine 0 CA--C 1.511 -0.206 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.534 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 2.5 mt-30 -81.57 134.85 35.55 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.772 -0.714 . . . . 0.0 111.567 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -121.37 114.18 20.95 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.424 0.63 . . . . 0.0 109.759 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.8 m-85 -78.36 134.87 37.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.25 157.48 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.77 96.2 7.44 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.938 0.875 . . . . 0.0 110.942 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HG2' HG21 ' A' ' 21' ' ' VAL . 2.3 mmmt -110.79 136.37 49.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.754 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.2 t0 54.59 28.14 9.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.129 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.63 -1.18 89.11 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.018 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.8 mt-10 -119.6 160.77 21.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.376 0.607 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 80.2 m95 -84.84 132.35 34.41 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.743 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.614 HG21 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.28 130.74 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.72 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.24 127.36 36.64 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.461 1.124 . . . . 0.0 111.769 -177.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.61 -176.61 0.82 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.075 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m -75.14 -171.18 1.32 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.025 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.49 -71.36 0.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -87.02 -80.63 0.24 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.256 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.157 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -71.13 144.29 50.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mt -84.62 122.94 74.92 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.93 139.96 87.7 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.424 2.083 . . . . 0.0 112.211 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.05 155.56 40.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.276 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.83 153.41 84.25 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.625 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -41.14 127.61 2.87 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.717 2.278 . . . . 0.0 112.809 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -128.91 156.83 43.09 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -139.44 -4.28 1.47 Allowed 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.845 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.43 20.82 45.25 Favored Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.384 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -79.32 132.72 36.53 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.055 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -128.34 133.04 48.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.055 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.5 135.46 33.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.926 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 160.1 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.42 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -98.25 96.79 8.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.907 0.861 . . . . 0.0 110.016 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 19' ' ' GLU . 37.8 mmtt -109.51 137.29 47.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.877 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.7 t70 53.81 30.65 11.69 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.015 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.84 86.52 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.615 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.5 mt-10 -123.01 159.02 29.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.483 0.659 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.42 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.3 m95 -83.99 124.84 31.47 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.593 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.619 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -90.69 144.74 25.44 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.633 1.206 . . . . 0.0 113.01 -178.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.58 58.67 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.603 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m -78.87 176.0 10.0 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.83 0.347 . . . . 0.0 110.786 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.83 144.27 30.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.875 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -86.97 -24.48 24.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.858 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 120.727 0.299 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.994 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -94.71 134.17 37.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.419 0.628 . . . . 0.0 112.681 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.15 159.06 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.45 ' HG3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -98.93 96.13 7.63 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.8 0.81 . . . . 0.0 109.836 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HD3' ' CG2' ' A' ' 21' ' ' VAL . 1.4 mtpp -110.49 135.94 50.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.084 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 57.08 32.08 21.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.901 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.48 8.56 80.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.584 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.3 mt-10 -125.41 157.71 36.18 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.586 0.708 . . . . 0.0 110.885 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CE2' ' HG3' ' A' ' 15' ' ' ARG . 73.4 m95 -86.61 122.03 29.95 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.536 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -136.21 138.88 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.994 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.843 0 CA-C-O 122.77 1.271 . . . . 0.0 113.606 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 CA-C-O 121.393 0.616 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.842 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.8 m-85 -77.9 134.58 37.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.5 157.5 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 174.051 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 96.25 7.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.929 0.871 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' HG23 ' A' ' 21' ' ' VAL . 6.6 mmmm -110.57 136.64 49.37 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 53.93 28.63 8.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.53 0.01 89.59 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.966 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.6 mt-10 -119.85 159.78 23.93 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.451 0.643 . . . . 0.0 110.887 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.404 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.2 m95 -84.11 131.74 34.76 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.447 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.591 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -130.87 130.95 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.943 0 CA-C-O 122.492 1.139 . . . . 0.0 112.277 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.019 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.99 135.05 33.76 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.76 159.95 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.8 OUTLIER -99.27 96.82 8.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.056 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' GLU . 3.2 mmtp -109.73 136.65 48.73 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.98 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 54.06 30.67 12.31 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.04 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.73 2.3 88.04 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.817 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.9 mt-10 -121.07 160.24 24.05 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.525 0.679 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.424 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 78.8 m95 -86.26 125.32 33.49 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 137.59 45.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.019 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 122.753 1.264 . . . . 0.0 113.212 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.247 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.03 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.12 135.44 33.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.944 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.89 161.3 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -99.63 96.17 7.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.934 0.873 . . . . 0.0 110.195 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' GLU . 1.5 mmmm -110.93 137.1 48.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.934 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.0 t0 55.57 30.85 16.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.87 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.15 79.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.388 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -122.61 157.18 32.73 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.51 0.671 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -82.92 123.3 29.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.958 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -134.08 135.58 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.03 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.961 0 CA-C-O 122.833 1.302 . . . . 0.0 113.228 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 121.536 0.684 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.837 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.9 m-85 -79.24 136.07 36.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.581 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.7 157.79 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 173.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.2 96.12 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.949 0.88 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.576 ' HG2' HG23 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.3 136.78 48.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.682 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.3 t0 54.64 28.46 10.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.191 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.25 0.79 90.09 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.036 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -121.42 160.65 23.68 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.426 0.631 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -84.18 131.69 34.74 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.657 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.7 131.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 176.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.994 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 122.353 1.073 . . . . 0.0 111.544 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.017 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -91.02 134.31 34.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.91 159.87 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -97.46 96.48 8.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.931 0.872 . . . . 0.0 109.632 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HD2' ' HB ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.52 136.67 49.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.861 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 56.77 30.5 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.917 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.47 5.68 82.82 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.653 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -124.96 160.32 29.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.524 0.678 . . . . 0.0 110.849 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.411 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 77.9 m95 -85.47 120.96 27.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HB ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -135.66 139.85 45.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.017 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.501 -0.915 0 CA-C-O 122.674 1.226 . . . . 0.0 113.397 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.063 0.458 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.022 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -90.18 135.59 33.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.41 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.77 159.39 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -99.94 96.52 7.6 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.871 0.843 . . . . 0.0 110.173 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' GLU . 2.2 mmtp -110.03 136.12 49.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.038 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.31 30.29 12.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.941 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.39 88.2 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.769 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -118.46 159.79 22.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.627 0.727 . . . . 0.0 110.952 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.407 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 76.2 m95 -87.12 126.57 34.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.613 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.96 135.31 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.022 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 122.777 1.275 . . . . 0.0 113.539 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 121.011 0.434 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.032 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.76 136.34 33.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.995 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.56 159.34 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 1.6 ttt180 -98.93 96.59 7.95 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.874 0.845 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 19' ' ' GLU . 23.3 mmmt -110.43 137.03 48.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 54.92 30.46 14.0 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.069 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.33 87.21 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.745 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.4 mt-10 -122.65 159.84 27.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.514 0.673 . . . . 0.0 110.889 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.439 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.2 m95 -85.43 126.65 33.96 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 136.54 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 122.823 1.297 . . . . 0.0 113.516 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.424 0.63 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.823 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.8 m-85 -78.36 134.87 37.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.25 157.48 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.77 96.2 7.44 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.938 0.875 . . . . 0.0 110.942 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.595 ' HG2' HG23 ' A' ' 21' ' ' VAL . 2.3 mmmt -110.79 136.37 49.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.754 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.2 t0 54.59 28.14 9.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.129 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.63 -1.18 89.11 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.018 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.8 mt-10 -119.6 160.77 21.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.376 0.607 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 80.2 m95 -84.84 132.35 34.41 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.743 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.28 130.74 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.976 0 CA-C-O 122.461 1.124 . . . . 0.0 111.769 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 120.93 0.395 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.023 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.5 135.46 33.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.926 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 160.1 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -98.25 96.79 8.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.907 0.861 . . . . 0.0 110.016 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 19' ' ' GLU . 37.8 mmtt -109.51 137.29 47.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.877 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.7 t70 53.81 30.65 11.69 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.015 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.84 86.52 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.615 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.5 mt-10 -123.01 159.02 29.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.483 0.659 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.438 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.3 m95 -83.99 124.84 31.47 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.593 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.023 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 122.633 1.206 . . . . 0.0 113.01 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.208 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 10.8 t80 -70.68 139.79 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.719 0.295 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 mt -100.57 98.85 8.74 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.417 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 94.8 Cg_endo -84.24 122.81 2.93 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.635 2.224 . . . . 0.0 112.391 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.87 84.94 1.24 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.013 0.435 . . . . 0.0 110.944 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.41 134.01 86.94 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.139 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.96 97.02 0.96 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.332 2.021 . . . . 0.0 111.955 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.522 ' HG3' ' H ' ' A' ' 10' ' ' GLY . 17.7 tpp85 -124.76 156.89 36.98 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.649 0.737 . . . . 0.0 110.392 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -143.45 10.13 1.64 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.928 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 8' ' ' ARG . . . -109.35 4.18 31.31 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.206 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -126.76 131.21 51.36 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.933 -0.634 . . . . 0.0 110.88 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -129.95 133.34 46.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.402 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.994 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -94.71 134.17 37.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.419 0.628 . . . . 0.0 112.681 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.15 159.06 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.45 ' HG3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -98.93 96.13 7.63 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.8 0.81 . . . . 0.0 109.836 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HD3' ' CG2' ' A' ' 21' ' ' VAL . 1.4 mtpp -110.49 135.94 50.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.084 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 57.08 32.08 21.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.901 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.48 8.56 80.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.584 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.3 mt-10 -125.41 157.71 36.18 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.586 0.708 . . . . 0.0 110.885 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CE2' ' HG3' ' A' ' 15' ' ' ARG . 73.4 m95 -86.61 122.03 29.95 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.536 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -136.21 138.88 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.994 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -92.8 145.21 24.57 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 122.77 1.271 . . . . 0.0 113.606 -178.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -165.22 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 112.392 -2.186 . . . . 0.0 110.154 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.91 149.61 29.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.9 0.381 . . . . 0.0 111.043 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -77.27 -79.02 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.027 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.587 ' H ' HG23 ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.75 153.11 21.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.948 0.404 . . . . 0.0 110.853 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.003 -179.89 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.404 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 26.7 m-85 -99.15 141.27 32.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.811 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.05 98.99 7.11 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.47 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 74.1 Cg_endo -74.52 126.14 10.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.418 2.079 . . . . 0.0 112.177 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.54 110.16 6.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.889 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.67 120.63 76.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.6 141.07 75.42 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.35 2.033 . . . . 0.0 112.121 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.44 154.26 36.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.567 0.699 . . . . 0.0 110.476 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . 13.5 t0 -147.41 14.71 1.11 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.436 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.06 10.42 56.35 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.699 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 3.6 mm100 -81.03 134.49 35.68 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.635 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.98 113.9 20.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.393 0.616 . . . . 0.0 109.787 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.842 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.8 m-85 -77.9 134.58 37.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.5 157.5 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 174.051 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 96.25 7.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.929 0.871 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' HG23 ' A' ' 21' ' ' VAL . 6.6 mmmm -110.57 136.64 49.37 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 53.93 28.63 8.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.53 0.01 89.59 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.966 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.6 mt-10 -119.85 159.78 23.93 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.451 0.643 . . . . 0.0 110.887 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.404 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.2 m95 -84.11 131.74 34.76 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.447 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.591 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -130.87 130.95 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.48 129.49 37.45 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 122.492 1.139 . . . . 0.0 112.277 -177.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.3 mt -77.41 -175.43 3.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 112.845 -1.98 . . . . 0.0 111.167 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -159.7 55.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.598 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -81.46 -102.19 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.148 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.442 ' H ' HG23 ' A' ' 25' ' ' THR . 54.2 p90 -87.32 -164.67 1.12 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.624 0.249 . . . . 0.0 110.922 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 27' ' ' LEU . 2.0 mm? . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -100.86 116.51 32.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.841 HD12 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -77.81 112.44 24.79 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.242 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.45 149.46 65.87 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.508 2.139 . . . . 0.0 112.195 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.4 90.29 1.28 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.038 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.55 ' N ' ' CD ' ' A' ' 7' ' ' PRO . . . -70.85 -39.65 9.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.925 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 6' ' ' ALA . 89.0 Cg_exo -47.4 105.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.265 1.977 . . . . 0.0 112.611 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.95 158.24 34.08 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.593 0.711 . . . . 0.0 110.527 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -144.43 11.52 1.49 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.437 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.28 8.69 51.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.659 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -88.68 134.66 33.83 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.7 -0.75 . . . . 0.0 111.064 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -126.75 128.42 46.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.088 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.019 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.99 135.05 33.76 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.76 159.95 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.8 OUTLIER -99.27 96.82 8.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.056 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' GLU . 3.2 mmtp -109.73 136.65 48.73 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.98 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 54.06 30.67 12.31 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.04 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.73 2.3 88.04 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.817 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.9 mt-10 -121.07 160.24 24.05 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.525 0.679 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.424 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 78.8 m95 -86.26 125.32 33.49 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 137.59 45.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.019 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -90.85 143.89 26.26 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 122.753 1.264 . . . . 0.0 113.212 -178.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 12' ' ' ALA . 52.6 mt -62.45 -165.98 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.86 -156.86 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.378 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -72.52 -60.54 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.796 0.332 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -87.24 -60.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.775 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.901 -0.08 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -74.69 128.98 36.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.106 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.1 118.62 67.85 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.561 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.2 161.6 10.94 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.521 2.147 . . . . 0.0 112.247 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.84 82.43 0.46 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.469 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.677 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -72.36 -46.29 10.44 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.525 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -43.97 113.68 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.533 2.155 . . . . 0.0 112.784 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -124.93 156.72 37.54 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.622 0.725 . . . . 0.0 110.743 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.593 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . 8.4 t70 -145.9 12.55 1.27 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.303 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.37 8.77 59.9 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.541 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' A' ' 9' ' ' ASP . 38.3 mt-30 -85.52 131.4 34.38 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.782 -0.709 . . . . 0.0 111.329 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -122.86 123.55 41.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.03 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.12 135.44 33.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.944 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.89 161.3 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -99.63 96.17 7.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.934 0.873 . . . . 0.0 110.195 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' GLU . 1.5 mmmm -110.93 137.1 48.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.934 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.0 t0 55.57 30.85 16.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.87 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.15 79.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.388 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -122.61 157.18 32.73 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.51 0.671 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -82.92 123.3 29.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.958 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -134.08 135.58 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.03 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -91.08 145.2 24.89 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.833 1.302 . . . . 0.0 113.228 -178.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 12' ' ' ALA . 19.3 mt -67.43 -1.26 4.56 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 112.299 -2.228 . . . . 0.0 112.08 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 11' ' ' GLN . 0.4 OUTLIER -83.04 161.27 21.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.901 0.381 . . . . 0.0 111.266 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.4 t -84.41 -172.99 4.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.526 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -86.84 142.16 28.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.951 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.475 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -105.51 104.25 13.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.744 0.307 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.19 105.71 37.48 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.265 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.59 113.32 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.401 2.067 . . . . 0.0 112.029 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.25 81.09 1.0 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.0 111.128 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.39 118.13 67.39 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.035 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.56 94.32 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.244 1.963 . . . . 0.0 111.939 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.34 156.35 42.13 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.592 0.711 . . . . 0.0 110.499 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -143.44 11.33 1.7 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.404 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.93 8.33 57.65 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.503 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -89.46 134.0 34.3 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.624 -0.788 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' A' ' 23' ' ' LEU . . . -122.71 113.58 19.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.04 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.837 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.9 m-85 -79.24 136.07 36.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.581 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.7 157.79 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 173.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.2 96.12 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.949 0.88 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.576 ' HG2' HG23 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.3 136.78 48.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.682 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.3 t0 54.64 28.46 10.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.191 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.25 0.79 90.09 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.036 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -121.42 160.65 23.68 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.426 0.631 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -84.18 131.69 34.74 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.657 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.7 131.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 176.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.994 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -90.93 135.22 33.88 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.353 1.073 . . . . 0.0 111.544 -177.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 12' ' ' ALA . 41.4 mt -70.36 46.21 0.08 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.735 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 t -89.75 89.4 7.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.64 0.257 . . . . 0.0 110.534 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.1 m -78.29 -85.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.766 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.93 -27.33 15.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.79 0.328 . . . . 0.0 110.984 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -77.35 144.61 37.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.704 0.288 . . . . 0.0 110.815 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.837 HD12 ' H ' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -78.1 111.15 16.35 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.253 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.1 144.67 30.2 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.453 2.102 . . . . 0.0 112.38 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -72.3 87.34 1.13 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.005 0.431 . . . . 0.0 110.805 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.608 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -67.21 -46.25 50.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.727 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 39.2 Cg_endo -67.0 128.12 18.11 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.766 1.644 . . . . 0.0 111.986 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -124.55 155.79 38.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.687 0.756 . . . . 0.0 110.222 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -142.55 15.19 1.99 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.059 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.31 4.13 63.38 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.591 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -96.17 147.45 23.74 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.76 -0.72 . . . . 0.0 111.297 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -127.75 135.55 50.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.369 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.017 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -91.02 134.31 34.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.91 159.87 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -97.46 96.48 8.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.931 0.872 . . . . 0.0 109.632 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HD2' ' HB ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.52 136.67 49.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.861 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 56.77 30.5 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.917 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.47 5.68 82.82 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.653 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -124.96 160.32 29.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.524 0.678 . . . . 0.0 110.849 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.411 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 77.9 m95 -85.47 120.96 27.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HB ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -135.66 139.85 45.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.017 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -92.17 144.4 25.46 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 122.674 1.226 . . . . 0.0 113.397 -178.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mt -66.44 -169.58 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 112.5 -2.136 . . . . 0.0 110.012 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -152.97 117.62 5.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 t -82.98 -172.28 4.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.816 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -87.22 -69.04 0.71 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.869 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -70.59 143.71 51.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.782 0.325 . . . . 0.0 111.02 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -88.95 112.33 50.17 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.176 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.11 123.2 13.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.307 2.005 . . . . 0.0 112.208 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -72.95 95.65 2.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.253 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.98 122.89 88.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.66 140.84 24.13 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.346 2.031 . . . . 0.0 112.154 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -113.15 153.23 28.59 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.628 0.727 . . . . 0.0 110.084 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -147.76 10.83 0.95 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.432 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.32 3.55 61.73 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.253 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -125.55 132.45 52.58 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.482 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -128.56 124.97 37.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.063 0.458 . . . . 0.0 110.381 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.022 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -90.18 135.59 33.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.41 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.77 159.39 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -99.94 96.52 7.6 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.871 0.843 . . . . 0.0 110.173 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' GLU . 2.2 mmtp -110.03 136.12 49.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.038 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.31 30.29 12.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.941 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.39 88.2 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.769 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -118.46 159.79 22.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.627 0.727 . . . . 0.0 110.952 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.407 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 76.2 m95 -87.12 126.57 34.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.613 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.96 135.31 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.022 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -91.6 143.88 26.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.777 1.275 . . . . 0.0 113.539 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.61 -174.83 0.22 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 112.268 -2.242 . . . . 0.0 110.895 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 t -72.09 134.96 46.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.831 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.0 149.11 28.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -125.61 -68.02 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.591 -0.203 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -119.49 104.11 10.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 0.0 110.703 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.05 108.99 36.68 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.71 146.64 61.11 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.492 2.128 . . . . 0.0 111.974 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.06 84.31 0.99 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.529 ' N ' ' CD ' ' A' ' 7' ' ' PRO . . . -72.86 -40.75 6.46 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.909 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 6' ' ' ALA . 80.1 Cg_exo -47.73 101.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.133 1.889 . . . . 0.0 112.422 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.447 ' HG2' ' H ' ' A' ' 10' ' ' GLY . 13.3 ttp-105 -124.99 154.27 41.48 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.498 0.666 . . . . 0.0 110.675 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -145.23 11.19 1.32 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.476 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 8' ' ' ARG . . . 71.31 7.55 63.9 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.122 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -95.52 135.84 36.66 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.413 -0.894 . . . . 0.0 110.946 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -127.08 128.3 46.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.011 0.434 . . . . 0.0 110.078 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.032 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.76 136.34 33.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.995 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.56 159.34 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 1.6 ttt180 -98.93 96.59 7.95 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.874 0.845 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 19' ' ' GLU . 23.3 mmmt -110.43 137.03 48.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 54.92 30.46 14.0 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.069 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.33 87.21 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.745 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.4 mt-10 -122.65 159.84 27.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.514 0.673 . . . . 0.0 110.889 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.439 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.2 m95 -85.43 126.65 33.96 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 136.54 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -91.27 143.38 26.71 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.823 1.297 . . . . 0.0 113.516 -178.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' A' ' 24' ' ' SER . 1.0 OUTLIER -64.21 -159.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 112.086 -2.324 . . . . 0.0 110.278 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 23' ' ' LEU . 1.7 t 49.38 106.09 0.0 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.972 0.415 . . . . 0.0 111.852 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.6 m -78.02 153.45 32.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.152 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -91.9 -176.28 4.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.615 ' C ' HD13 ' A' ' 27' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.432 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -73.34 111.79 8.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.99 105.54 12.63 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.279 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.81 116.37 4.53 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.388 2.058 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.23 144.61 46.68 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.293 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.15 118.6 63.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.01 136.17 9.07 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.572 2.181 . . . . 0.0 112.749 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.414 ' HG3' ' H ' ' A' ' 10' ' ' GLY . 4.1 tpp180 -120.3 155.98 32.2 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.569 0.7 . . . . 0.0 110.24 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . 16.6 t0 -147.36 13.58 1.09 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.759 -1.109 . . . . 0.0 113.145 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 8' ' ' ARG . . . 63.49 11.45 41.35 Favored Glycine 0 CA--C 1.511 -0.206 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.534 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.758 HE22 HD23 ' A' ' 22' ' ' LEU . 2.5 mt-30 -81.57 134.85 35.55 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.772 -0.714 . . . . 0.0 111.567 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -121.37 114.18 20.95 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.424 0.63 . . . . 0.0 109.759 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.823 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.8 m-85 -78.36 134.87 37.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.25 157.48 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.77 96.2 7.44 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.938 0.875 . . . . 0.0 110.942 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.595 ' HG2' HG23 ' A' ' 21' ' ' VAL . 2.3 mmmt -110.79 136.37 49.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.754 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.2 t0 54.59 28.14 9.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.129 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.63 -1.18 89.11 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.018 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.8 mt-10 -119.6 160.77 21.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.376 0.607 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 80.2 m95 -84.84 132.35 34.41 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.743 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.28 130.74 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.24 127.36 36.64 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.461 1.124 . . . . 0.0 111.769 -177.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.61 -176.61 0.82 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.075 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m -75.14 -171.18 1.32 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.025 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.49 -71.36 0.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -87.02 -80.63 0.24 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.256 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.157 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -71.13 144.29 50.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mt -84.62 122.94 74.92 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.93 139.96 87.7 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.424 2.083 . . . . 0.0 112.211 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.05 155.56 40.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.276 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.83 153.41 84.25 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.625 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -41.14 127.61 2.87 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.717 2.278 . . . . 0.0 112.809 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -128.91 156.83 43.09 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -139.44 -4.28 1.47 Allowed 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.845 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.43 20.82 45.25 Favored Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.384 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -79.32 132.72 36.53 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.055 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -128.34 133.04 48.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.055 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.023 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.5 135.46 33.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.926 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 160.1 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -98.25 96.79 8.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.907 0.861 . . . . 0.0 110.016 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 19' ' ' GLU . 37.8 mmtt -109.51 137.29 47.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.877 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.7 t70 53.81 30.65 11.69 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.015 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.84 86.52 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.615 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.5 mt-10 -123.01 159.02 29.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.483 0.659 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.438 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.3 m95 -83.99 124.84 31.47 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.593 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.023 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -90.69 144.74 25.44 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.633 1.206 . . . . 0.0 113.01 -178.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.58 58.67 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.603 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m -78.87 176.0 10.0 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.83 0.347 . . . . 0.0 110.786 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.83 144.27 30.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.875 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -86.97 -24.48 24.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.858 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 120.727 0.299 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.994 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -94.71 134.17 37.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.419 0.628 . . . . 0.0 112.681 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.15 159.06 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.45 ' HG3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -98.93 96.13 7.63 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.8 0.81 . . . . 0.0 109.836 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HD3' ' CG2' ' A' ' 21' ' ' VAL . 1.4 mtpp -110.49 135.94 50.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.084 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 57.08 32.08 21.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.901 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.48 8.56 80.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.584 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.3 mt-10 -125.41 157.71 36.18 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.586 0.708 . . . . 0.0 110.885 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CE2' ' HG3' ' A' ' 15' ' ' ARG . 73.4 m95 -86.61 122.03 29.95 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.536 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -136.21 138.88 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.994 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.843 0 CA-C-O 122.77 1.271 . . . . 0.0 113.606 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 CA-C-O 121.393 0.616 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.842 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.8 m-85 -77.9 134.58 37.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.5 157.5 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 174.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 96.25 7.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.929 0.871 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' HG23 ' A' ' 21' ' ' VAL . 6.6 mmmm -110.57 136.64 49.37 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 53.93 28.63 8.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.53 0.01 89.59 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.966 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.6 mt-10 -119.85 159.78 23.93 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.451 0.643 . . . . 0.0 110.887 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.404 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.2 m95 -84.11 131.74 34.76 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.447 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.591 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -130.87 130.95 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.943 0 CA-C-O 122.492 1.139 . . . . 0.0 112.277 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.019 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.99 135.05 33.76 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.76 159.95 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.8 OUTLIER -99.27 96.82 8.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.056 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' GLU . 3.2 mmtp -109.73 136.65 48.73 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.98 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 54.06 30.67 12.31 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.04 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.73 2.3 88.04 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.817 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.9 mt-10 -121.07 160.24 24.05 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.525 0.679 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.424 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 78.8 m95 -86.26 125.32 33.49 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 137.59 45.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.019 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 122.753 1.264 . . . . 0.0 113.212 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.247 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.03 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.12 135.44 33.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.944 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.89 161.3 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -99.63 96.17 7.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.934 0.873 . . . . 0.0 110.195 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' GLU . 1.5 mmmm -110.93 137.1 48.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.934 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.0 t0 55.57 30.85 16.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.87 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.15 79.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.388 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -122.61 157.18 32.73 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.51 0.671 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -82.92 123.3 29.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.958 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -134.08 135.58 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.03 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.961 0 CA-C-O 122.833 1.302 . . . . 0.0 113.228 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 121.536 0.684 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.837 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.9 m-85 -79.24 136.07 36.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.581 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.7 157.79 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 173.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.2 96.12 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.949 0.88 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.576 ' HG2' HG23 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.3 136.78 48.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.682 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.3 t0 54.64 28.46 10.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.191 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.25 0.79 90.09 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.036 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -121.42 160.65 23.68 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.426 0.631 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -84.18 131.69 34.74 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.657 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.7 131.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 176.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.994 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 122.353 1.073 . . . . 0.0 111.544 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.017 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -91.02 134.31 34.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.91 159.87 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -97.46 96.48 8.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.931 0.872 . . . . 0.0 109.632 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HD2' ' HB ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.52 136.67 49.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.861 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 56.77 30.5 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.917 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.47 5.68 82.82 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.653 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -124.96 160.32 29.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.524 0.678 . . . . 0.0 110.849 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.411 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 77.9 m95 -85.47 120.96 27.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HB ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -135.66 139.85 45.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.017 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.501 -0.915 0 CA-C-O 122.674 1.226 . . . . 0.0 113.397 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.063 0.458 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.022 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -90.18 135.59 33.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.41 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.77 159.39 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -99.94 96.52 7.6 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.871 0.843 . . . . 0.0 110.173 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' GLU . 2.2 mmtp -110.03 136.12 49.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.038 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.31 30.29 12.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.941 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.39 88.2 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.769 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -118.46 159.79 22.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.627 0.727 . . . . 0.0 110.952 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.407 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 76.2 m95 -87.12 126.57 34.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.613 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.96 135.31 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.022 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 122.777 1.275 . . . . 0.0 113.539 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 121.011 0.434 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.032 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.76 136.34 33.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.995 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.56 159.34 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 1.6 ttt180 -98.93 96.59 7.95 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.874 0.845 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 19' ' ' GLU . 23.3 mmmt -110.43 137.03 48.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 54.92 30.46 14.0 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.069 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.33 87.21 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.745 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.4 mt-10 -122.65 159.84 27.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.514 0.673 . . . . 0.0 110.889 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.439 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.2 m95 -85.43 126.65 33.96 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 136.54 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 122.823 1.297 . . . . 0.0 113.516 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.424 0.63 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.823 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.8 m-85 -78.36 134.87 37.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.25 157.48 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.77 96.2 7.44 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.938 0.875 . . . . 0.0 110.942 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.595 ' HG2' HG23 ' A' ' 21' ' ' VAL . 2.3 mmmt -110.79 136.37 49.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.754 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.2 t0 54.59 28.14 9.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.129 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.63 -1.18 89.11 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.018 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.8 mt-10 -119.6 160.77 21.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.376 0.607 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 80.2 m95 -84.84 132.35 34.41 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.743 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.28 130.74 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.01 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.976 0 CA-C-O 122.461 1.124 . . . . 0.0 111.769 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 120.93 0.395 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.023 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.5 135.46 33.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.926 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 160.1 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -98.25 96.79 8.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.907 0.861 . . . . 0.0 110.016 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 19' ' ' GLU . 37.8 mmtt -109.51 137.29 47.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.877 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.7 t70 53.81 30.65 11.69 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.015 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.84 86.52 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.615 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.5 mt-10 -123.01 159.02 29.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.483 0.659 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.438 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.3 m95 -83.99 124.84 31.47 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.593 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.023 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 122.633 1.206 . . . . 0.0 113.01 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.208 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 10.8 t80 -70.68 139.79 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.719 0.295 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 mt -100.57 98.85 8.74 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.417 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 94.8 Cg_endo -84.24 122.81 2.93 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.635 2.224 . . . . 0.0 112.391 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -72.87 84.94 1.24 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.013 0.435 . . . . 0.0 110.944 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.41 134.01 86.94 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.139 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.96 97.02 0.96 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.332 2.021 . . . . 0.0 111.955 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.522 ' HG3' ' H ' ' A' ' 10' ' ' GLY . 17.7 tpp85 -124.76 156.89 36.98 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.649 0.737 . . . . 0.0 110.392 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -143.45 10.13 1.64 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.928 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 8' ' ' ARG . . . -109.35 4.18 31.31 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.206 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -126.76 131.21 51.36 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.933 -0.634 . . . . 0.0 110.88 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -129.95 133.34 46.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.402 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.994 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -94.71 134.17 37.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.419 0.628 . . . . 0.0 112.681 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.15 159.06 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 174.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.45 ' HG3' ' CE2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -98.93 96.13 7.63 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.8 0.81 . . . . 0.0 109.836 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HD3' ' CG2' ' A' ' 21' ' ' VAL . 1.4 mtpp -110.49 135.94 50.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.084 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.1 t70 57.08 32.08 21.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.901 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.48 8.56 80.77 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.584 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.3 mt-10 -125.41 157.71 36.18 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 121.586 0.708 . . . . 0.0 110.885 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CE2' ' HG3' ' A' ' 15' ' ' ARG . 73.4 m95 -86.61 122.03 29.95 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.536 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG2' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -136.21 138.88 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.994 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -92.8 145.21 24.57 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 122.77 1.271 . . . . 0.0 113.606 -178.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -165.22 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 112.392 -2.186 . . . . 0.0 110.154 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.91 149.61 29.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.9 0.381 . . . . 0.0 111.043 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -77.27 -79.02 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.027 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.587 ' H ' HG23 ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.75 153.11 21.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.948 0.404 . . . . 0.0 110.853 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.003 -179.89 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.404 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 26.7 m-85 -99.15 141.27 32.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.811 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mt -99.05 98.99 7.11 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.47 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 2' ' ' TYR . 74.1 Cg_endo -74.52 126.14 10.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.418 2.079 . . . . 0.0 112.177 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.54 110.16 6.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.889 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.67 120.63 76.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.6 141.07 75.42 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.35 2.033 . . . . 0.0 112.121 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.44 154.26 36.79 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.567 0.699 . . . . 0.0 110.476 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . 13.5 t0 -147.41 14.71 1.11 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.436 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.06 10.42 56.35 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.699 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 3.6 mm100 -81.03 134.49 35.68 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.635 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.98 113.9 20.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.393 0.616 . . . . 0.0 109.787 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.842 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.8 m-85 -77.9 134.58 37.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.5 157.5 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 174.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 96.25 7.38 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.929 0.871 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' HG23 ' A' ' 21' ' ' VAL . 6.6 mmmm -110.57 136.64 49.37 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.774 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 53.93 28.63 8.79 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.53 0.01 89.59 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.966 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.6 mt-10 -119.85 159.78 23.93 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.451 0.643 . . . . 0.0 110.887 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.404 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.2 m95 -84.11 131.74 34.76 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.447 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.591 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -130.87 130.95 64.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.48 129.49 37.45 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 122.492 1.139 . . . . 0.0 112.277 -177.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.3 mt -77.41 -175.43 3.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 112.845 -1.98 . . . . 0.0 111.167 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -159.7 55.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.598 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -81.46 -102.19 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.148 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.442 ' H ' HG23 ' A' ' 25' ' ' THR . 54.2 p90 -87.32 -164.67 1.12 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.624 0.249 . . . . 0.0 110.922 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 27' ' ' LEU . 2.0 mm? . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -100.86 116.51 32.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.841 HD12 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -77.81 112.44 24.79 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.242 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.45 149.46 65.87 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.508 2.139 . . . . 0.0 112.195 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.4 90.29 1.28 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.038 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.55 ' N ' ' CD ' ' A' ' 7' ' ' PRO . . . -70.85 -39.65 9.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.925 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 6' ' ' ALA . 89.0 Cg_exo -47.4 105.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.265 1.977 . . . . 0.0 112.611 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.95 158.24 34.08 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.593 0.711 . . . . 0.0 110.527 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -144.43 11.52 1.49 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.437 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.28 8.69 51.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.659 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -88.68 134.66 33.83 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.7 -0.75 . . . . 0.0 111.064 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -126.75 128.42 46.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.088 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.019 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.99 135.05 33.76 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.76 159.95 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.424 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.8 OUTLIER -99.27 96.82 8.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.896 0.855 . . . . 0.0 110.056 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 19' ' ' GLU . 3.2 mmtp -109.73 136.65 48.73 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.98 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 54.06 30.67 12.31 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.04 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.73 2.3 88.04 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.817 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.9 mt-10 -121.07 160.24 24.05 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 121.525 0.679 . . . . 0.0 110.951 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.424 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 78.8 m95 -86.26 125.32 33.49 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 137.59 45.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.019 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -90.85 143.89 26.26 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 122.753 1.264 . . . . 0.0 113.212 -178.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 12' ' ' ALA . 52.6 mt -62.45 -165.98 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 112.238 -2.255 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.86 -156.86 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.378 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m -72.52 -60.54 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.796 0.332 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -87.24 -60.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.775 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.901 -0.08 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -74.69 128.98 36.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 111.106 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.1 118.62 67.85 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.561 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.2 161.6 10.94 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.521 2.147 . . . . 0.0 112.247 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.84 82.43 0.46 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.469 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.677 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -72.36 -46.29 10.44 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.525 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 1.0 OUTLIER -43.97 113.68 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.533 2.155 . . . . 0.0 112.784 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -124.93 156.72 37.54 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.622 0.725 . . . . 0.0 110.743 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.593 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . 8.4 t70 -145.9 12.55 1.27 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.303 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.37 8.77 59.9 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.541 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' A' ' 9' ' ' ASP . 38.3 mt-30 -85.52 131.4 34.38 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.782 -0.709 . . . . 0.0 111.329 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -122.86 123.55 41.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.03 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.12 135.44 33.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.944 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.89 161.3 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 ttm-85 -99.63 96.17 7.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.934 0.873 . . . . 0.0 110.195 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' GLU . 1.5 mmmm -110.93 137.1 48.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.934 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.0 t0 55.57 30.85 16.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.87 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.46 4.15 79.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.388 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -122.61 157.18 32.73 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-O 121.51 0.671 . . . . 0.0 110.839 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -82.92 123.3 29.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.958 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -134.08 135.58 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.03 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -91.08 145.2 24.89 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.833 1.302 . . . . 0.0 113.228 -178.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 12' ' ' ALA . 19.3 mt -67.43 -1.26 4.56 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 112.299 -2.228 . . . . 0.0 112.08 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 11' ' ' GLN . 0.4 OUTLIER -83.04 161.27 21.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.901 0.381 . . . . 0.0 111.266 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.4 t -84.41 -172.99 4.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.526 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -86.84 142.16 28.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.951 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.475 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -105.51 104.25 13.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.744 0.307 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.19 105.71 37.48 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.265 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.59 113.32 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.401 2.067 . . . . 0.0 112.029 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.25 81.09 1.0 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.0 111.128 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.39 118.13 67.39 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.035 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.56 94.32 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.244 1.963 . . . . 0.0 111.939 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.34 156.35 42.13 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.592 0.711 . . . . 0.0 110.499 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -143.44 11.33 1.7 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.404 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.93 8.33 57.65 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.503 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -89.46 134.0 34.3 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.624 -0.788 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' A' ' 23' ' ' LEU . . . -122.71 113.58 19.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.04 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.837 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.9 m-85 -79.24 136.07 36.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.581 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.7 157.79 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 173.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.2 96.12 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.949 0.88 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.576 ' HG2' HG23 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.3 136.78 48.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 113.953 -1.476 . . . . 0.0 111.682 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.3 t0 54.64 28.46 10.01 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.191 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.25 0.79 90.09 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.036 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -121.42 160.65 23.68 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.426 0.631 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -84.18 131.69 34.74 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.657 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.576 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.7 131.76 62.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 176.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.994 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -90.93 135.22 33.88 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.353 1.073 . . . . 0.0 111.544 -177.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 12' ' ' ALA . 41.4 mt -70.36 46.21 0.08 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.077 -1.874 . . . . 0.0 111.735 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 t -89.75 89.4 7.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.64 0.257 . . . . 0.0 110.534 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.1 m -78.29 -85.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.766 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.93 -27.33 15.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.79 0.328 . . . . 0.0 110.984 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.856 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -77.35 144.61 37.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.704 0.288 . . . . 0.0 110.815 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.837 HD12 ' H ' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -78.1 111.15 16.35 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.253 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.1 144.67 30.2 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.453 2.102 . . . . 0.0 112.38 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -72.3 87.34 1.13 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.005 0.431 . . . . 0.0 110.805 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.608 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -67.21 -46.25 50.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.727 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 39.2 Cg_endo -67.0 128.12 18.11 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.766 1.644 . . . . 0.0 111.986 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -124.55 155.79 38.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.687 0.756 . . . . 0.0 110.222 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -142.55 15.19 1.99 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.059 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.31 4.13 63.38 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.591 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -96.17 147.45 23.74 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.76 -0.72 . . . . 0.0 111.297 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -127.75 135.55 50.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.369 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.017 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -91.02 134.31 34.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.91 159.87 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 173.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -97.46 96.48 8.36 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.931 0.872 . . . . 0.0 109.632 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' HD2' ' HB ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -110.52 136.67 49.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.861 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 56.77 30.5 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.917 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.47 5.68 82.82 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.653 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 16' ' ' LYS . 29.2 mt-10 -124.96 160.32 29.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.524 0.678 . . . . 0.0 110.849 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.411 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 77.9 m95 -85.47 120.96 27.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.432 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HB ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -135.66 139.85 45.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.017 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -92.17 144.4 25.46 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 122.674 1.226 . . . . 0.0 113.397 -178.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mt -66.44 -169.58 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 112.5 -2.136 . . . . 0.0 110.012 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -152.97 117.62 5.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 t -82.98 -172.28 4.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.816 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -87.22 -69.04 0.71 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.869 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -70.59 143.71 51.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.782 0.325 . . . . 0.0 111.02 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -88.95 112.33 50.17 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.176 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.11 123.2 13.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.307 2.005 . . . . 0.0 112.208 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -72.95 95.65 2.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.253 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.98 122.89 88.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.66 140.84 24.13 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.346 2.031 . . . . 0.0 112.154 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -113.15 153.23 28.59 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.628 0.727 . . . . 0.0 110.084 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -147.76 10.83 0.95 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.432 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.32 3.55 61.73 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.253 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -125.55 132.45 52.58 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.482 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -128.56 124.97 37.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.063 0.458 . . . . 0.0 110.381 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.022 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -90.18 135.59 33.57 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.41 -179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.77 159.39 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -99.94 96.52 7.6 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.871 0.843 . . . . 0.0 110.173 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' GLU . 2.2 mmtp -110.03 136.12 49.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.038 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.31 30.29 12.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.941 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.85 0.39 88.2 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.769 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.7 mt-10 -118.46 159.79 22.87 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.627 0.727 . . . . 0.0 110.952 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.407 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 76.2 m95 -87.12 126.57 34.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.613 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.96 135.31 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.022 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -91.6 143.88 26.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.777 1.275 . . . . 0.0 113.539 -178.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.61 -174.83 0.22 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 112.268 -2.242 . . . . 0.0 110.895 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 t -72.09 134.96 46.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.831 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.0 149.11 28.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.992 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -125.61 -68.02 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.591 -0.203 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -119.49 104.11 10.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 0.0 110.703 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.05 108.99 36.68 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.378 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.71 146.64 61.11 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.492 2.128 . . . . 0.0 111.974 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.06 84.31 0.99 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.529 ' N ' ' CD ' ' A' ' 7' ' ' PRO . . . -72.86 -40.75 6.46 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.909 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 6' ' ' ALA . 80.1 Cg_exo -47.73 101.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.133 1.889 . . . . 0.0 112.422 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.447 ' HG2' ' H ' ' A' ' 10' ' ' GLY . 13.3 ttp-105 -124.99 154.27 41.48 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.498 0.666 . . . . 0.0 110.675 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -145.23 11.19 1.32 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.476 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 8' ' ' ARG . . . 71.31 7.55 63.9 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.122 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -95.52 135.84 36.66 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.413 -0.894 . . . . 0.0 110.946 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -127.08 128.3 46.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.011 0.434 . . . . 0.0 110.078 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.032 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -88.76 136.34 33.05 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.995 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.56 159.34 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 174.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 1.6 ttt180 -98.93 96.59 7.95 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.874 0.845 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 19' ' ' GLU . 23.3 mmmt -110.43 137.03 48.67 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.869 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 t70 54.92 30.46 14.0 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.069 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 3.33 87.21 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.745 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' LYS . 25.4 mt-10 -122.65 159.84 27.04 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.514 0.673 . . . . 0.0 110.889 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.439 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.2 m95 -85.43 126.65 33.96 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 136.54 45.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -91.27 143.38 26.71 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.823 1.297 . . . . 0.0 113.516 -178.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' A' ' 24' ' ' SER . 1.0 OUTLIER -64.21 -159.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 112.086 -2.324 . . . . 0.0 110.278 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 23' ' ' LEU . 1.7 t 49.38 106.09 0.0 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.972 0.415 . . . . 0.0 111.852 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.6 m -78.02 153.45 32.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.152 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -91.9 -176.28 4.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.615 ' C ' HD13 ' A' ' 27' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.432 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -73.34 111.79 8.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.99 105.54 12.63 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.279 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.81 116.37 4.53 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.388 2.058 . . . . 0.0 112.375 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.23 144.61 46.68 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.293 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.15 118.6 63.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.01 136.17 9.07 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.572 2.181 . . . . 0.0 112.749 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.414 ' HG3' ' H ' ' A' ' 10' ' ' GLY . 4.1 tpp180 -120.3 155.98 32.2 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.569 0.7 . . . . 0.0 110.24 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . 16.6 t0 -147.36 13.58 1.09 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 114.759 -1.109 . . . . 0.0 113.145 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 8' ' ' ARG . . . 63.49 11.45 41.35 Favored Glycine 0 CA--C 1.511 -0.206 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.534 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.758 HE22 HD23 ' A' ' 22' ' ' LEU . 2.5 mt-30 -81.57 134.85 35.55 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.772 -0.714 . . . . 0.0 111.567 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -121.37 114.18 20.95 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.424 0.63 . . . . 0.0 109.759 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.823 ' HD1' HD12 ' A' ' 22' ' ' LEU . 1.8 m-85 -78.36 134.87 37.39 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -122.25 157.48 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.77 96.2 7.44 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.938 0.875 . . . . 0.0 110.942 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.595 ' HG2' HG23 ' A' ' 21' ' ' VAL . 2.3 mmmt -110.79 136.37 49.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.059 -1.428 . . . . 0.0 111.754 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 47.2 t0 54.59 28.14 9.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.129 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.63 -1.18 89.11 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.018 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' LYS . 26.8 mt-10 -119.6 160.77 21.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.376 0.607 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 80.2 m95 -84.84 132.35 34.41 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.743 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -131.28 130.74 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.01 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.24 127.36 36.64 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.461 1.124 . . . . 0.0 111.769 -177.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.9 mt -68.61 -176.61 0.82 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.075 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 m -75.14 -171.18 1.32 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.025 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.49 -71.36 0.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -87.02 -80.63 0.24 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.256 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.157 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -71.13 144.29 50.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mt -84.62 122.94 74.92 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -60.93 139.96 87.7 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.424 2.083 . . . . 0.0 112.211 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.05 155.56 40.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.276 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.83 153.41 84.25 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.625 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -41.14 127.61 2.87 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.717 2.278 . . . . 0.0 112.809 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -128.91 156.83 43.09 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -139.44 -4.28 1.47 Allowed 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.845 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.43 20.82 45.25 Favored Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.384 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -79.32 132.72 36.53 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.055 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' LEU . . . -128.34 133.04 48.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.055 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.023 ' CD1' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -89.5 135.46 33.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.926 -178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.26 160.1 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -98.25 96.79 8.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.907 0.861 . . . . 0.0 110.016 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 19' ' ' GLU . 37.8 mmtt -109.51 137.29 47.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.877 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.7 t70 53.81 30.65 11.69 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.015 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.84 86.52 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.615 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 16' ' ' LYS . 24.5 mt-10 -123.01 159.02 29.25 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.483 0.659 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.438 ' CD2' ' HG3' ' A' ' 15' ' ' ARG . 79.3 m95 -83.99 124.84 31.47 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.593 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.65 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.023 HD12 ' CD1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -90.69 144.74 25.44 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 122.633 1.206 . . . . 0.0 113.01 -178.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.58 58.67 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 112.31 -2.223 . . . . 0.0 111.603 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m -78.87 176.0 10.0 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.83 0.347 . . . . 0.0 110.786 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.83 144.27 30.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.875 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -86.97 -24.48 24.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.858 -179.958 . . . . . . . . 0 0 . 1 stop_ save_